Document is current
Any future updates will be listed below
-
Authors
Jacob-Nascimento, Leile Camila
Anjos, Rosângela O.
Portilho, Moyra M.
Cavalcanti, Viviane M.
Paz, Adriane S.
Santos, Lorena G.
Sousa, Moisés S.
Costa, Julia G.
Silva, Mariane R.
Moreira, Patrícia S. S.
Kitron, Uriel
Weaver, Scott C.
Santiago, Mittermayer B.
Reis, Mitermayer G.
Ribeiro, Guilherme S.
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (440891/2016-7, 311365/2021-3 to G.S.R, 440891/2016-7, 311365/2021-3 to G.S.R, 440891/2016-7, 311365/2021-3 to G.S.R, 440891/2016-7, 311365/2021-3 to G.S.R, 440891/2016-7, 311365/2021-3 to G.S.R)
Fundação Oswaldo Cruz
Federal University of Bahia
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.130749/2016-01 to G.S.R)
Fundação de Amparo à Pesquisa do Estado da Bahia (PET0022/2016 to G.S.R)
Department of Science and Technology, Secretariat of Science, Technology and Strategic Inputs, Brazilian Ministry of Health
Clinical and Applied Research in Chikungunya Network
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 31 March 2025
First Online: 24 April 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (CAAE: 55904616.4.0000.0040). Written informed consent was used during both enrollment in the surveillance study and the first consultation at the rheumatological clinic to explain the study’s aims, procedures, risks, and benefits. The forms were signed by participants ≥ 18 years old and parents of participants < 18. Minors (aged 5–17) also signed an informed assent form.
: Not applicable.
: The authors declare no competing interests.
